NCT06290037

Brief Summary

The primary objective of this study is to verify the safety and validity of a VR driving simulator developed for evaluating the driving abilities of elderly drivers. This study also aims to establish indicators in VR driving simulator to evaluate high-risk group for driving, such as cognitive and physical abilities. Therefore, this study aims to measure the physical driving function, general physical function and cognitive function of elderly drivers. to identify the correlation between their outcomes and the VR driving simulator's result

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

10 months

First QC Date

February 14, 2024

Last Update Submit

February 25, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility of VR driving simulator

    A questionnaire evaluating symptoms of simulator sickness such as dizziness or nausea and comprehension of contents

    2 hours

  • Driving performance in simulator, measured by driving errors

    Driving performance in simulator will be measured by driving errors during VR simluation of driving. These errors will be evaluated based on the criteria used for driving license tests, including violations of traffic laws.

    15 minutes

Study Arms (1)

Elderly drivers

OTHER

Individuals over the age of 65 who are currently driving

Device: VR Driving SimulatorOther: Computerized Neurocognitive Function TestOther: Driver Test StationOther: Short Physical Performance BatteryOther: On-road field driving Test

Interventions

Evaluation of usual road driving abilities and assessment of response capabilities in accident-prone situations through a VR driving simulator

Elderly drivers

Evaluation of cognitive levels including attention and memory (the Trail Making Test, Digit Span Test, Auditory (or Visual) Continuous Performance Test , and Card Sorting)

Elderly drivers

Conducting qualified tests of a person's basic physical driving ability including steering, acceleration and braking, using Driver Test Station(Autoadapt AB, Stenkullen, Sweden)

Elderly drivers

Evaluation of functional capability and provide a measure of the biological age of an older individual by measuring lower extremity physical performance status(standing balance, walking speed, and chair stand tests).

Elderly drivers

Researchers and driver's license supervisors ride in the driver's license test vehicle to evaluate the subject's actual driving ability. the validity of the VR simulator by comparing the results of the VR simulator with the actual vehicle driving ability.

Elderly drivers

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Individuals over the age of 65 who are currently driving.
  • Individuals capable of understanding and following the researcher's instructions.
  • Individuals who can understand the purpose of the research and have consented to participate

You may not qualify if:

  • Those who have not signed the consent form.
  • Individuals with a history of severe dizziness or epilepsy.
  • Patients with restrictions on sitting in a wheelchair or chair for more than 30 minutes.
  • Patients with severe shoulder pain.
  • Patients whose range of motion in major joints is restricted by more than 50%.
  • Pregnant women.
  • Patients with pressure sores.
  • Patients with limitations on simulator use due to heterotopic ossification.
  • Patients with acute fractures.
  • Other patients for whom participation in the study is expected difficult.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

RECRUITING

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate clinical professor

Study Record Dates

First Submitted

February 14, 2024

First Posted

March 4, 2024

Study Start

March 15, 2024

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

March 4, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations